Gene · 4085
Papers3,516
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,516
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of key serum biomarkers for the diagnosis and metastatic prediction of osteosarcoma by analysis of immune cell infiltration. | Cancer Cell Int | 2022 | 35151325 | PubTator, text mining | PubMed |
| The spatial transcriptomic landscape of the healing mouse intestine following damage. | Nat Commun | 2022 | 35149721 | PubTator, text mining | PubMed |
| Molecular basis of the association between transcription regulators nuclear respiratory factor 1 and inhibitor of DNA binding protein 3 and the development of microvascular lesions. | Microvasc Res | 2022 | 35143811 | PubTator, text mining | PubMed |
| Targeting of MAD2L1 by miR-515-5p involves the regulation of cell cycle arrest and apoptosis of colorectal cancer cells. | Cell Biol Int | 2022 | 35143103 | PubTator, text mining | PubMed |
| Multiple 9-1-1 complexes promote homolog synapsis, DSB repair, and ATR signaling during mammalian meiosis. | Elife | 2022 | 35133274 | PubTator, text mining | PubMed |
| Identification of MAD2L1 as a Potential Biomarker in Hepatocellular Carcinoma via Comprehensive Bioinformatics Analysis. | Biomed Res Int | 2022 | 35132379 | PubTator, text mining | PubMed |
| Identification of Potential Key Genes and Molecular Mechanisms of Medulloblastoma Based on Integrated Bioinformatics Approach. | Biomed Res Int | 2022 | 35127939 | PubTator, text mining | PubMed |
| Uncovering potential genes in colorectal cancer based on integrated and DNA methylation analysis in the gene expression omnibus database. | BMC Cancer | 2022 | 35114976 | PubTator, text mining | PubMed |
| On the role of phase separation in the biogenesis of membraneless compartments. | EMBO J | 2022 | 35107832 | PubTator, text mining | PubMed |
| Hepatic loss of CerS2 induces cell division defects via a mad2-mediated pathway. | Clin Transl Med | 2022 | 35090093 | PubTator, text mining | PubMed |
| Genetic Aberrations and Interaction of NEK2 and TP53 Accelerate Aggressiveness of Multiple Myeloma. | Adv Sci (Weinh) | 2022 | 35088582 | PubTator, text mining | PubMed |
| Dual-functional significance of ATM-mediated phosphorylation of spindle assembly checkpoint component Bub3 in mitosis and the DNA damage response. | J Biol Chem | 2022 | 35085551 | PubTator, text mining | PubMed |
| TRIP13, identified as a hub gene of tumor progression, is the target of microRNA-4693-5p and a potential therapeutic target for colorectal cancer. | Cell Death Discov | 2022 | 35075117 | PubTator, text mining | PubMed |
| ACC2 is under-expressed in lung adenocarcinoma and predicts poor clinical outcomes. | J Cancer Res Clin Oncol | 2022 | 35066671 | PubTator, text mining | PubMed |
| Chitosan Nanoparticle-Based System: A New Insight into the Promising Controlled Release System for Lung Cancer Treatment. | Molecules | 2022 | 35056788 | PubTator, text mining | PubMed |
| Anticancer Effects and Molecular Action of 7-α-Hydroxyfrullanolide in G2/M-Phase Arrest and Apoptosis in Triple Negative Breast Cancer Cells. | Molecules | 2022 | 35056723 | PubTator, text mining | PubMed |
| Nek2 Kinase Signaling in Malaria, Bone, Immune and Kidney Disorders to Metastatic Cancers and Drug Resistance: Progress on Nek2 Inhibitor Development. | Molecules | 2022 | 35056661 | PubTator, text mining | PubMed |
| Biallelic BUB1 mutations cause microcephaly, developmental delay, and variable effects on cohesion and chromosome segregation. | Sci Adv | 2022 | 35044816 | PubTator, text mining | PubMed |
| Interrogating Kinase-Substrate Relationships with Proximity Labeling and Phosphorylation Enrichment. | J Proteome Res | 2022 | 35044772 | PubTator, text mining | PubMed |
| Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | Mol Syst Biol | 2022 | 35044719 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4085/papers?page=31